Stock listing

NASDAQ:FCSC Fibrocell Science Inc Stock

Follow Fibrocell Science Inc into a list and get an email when it puts out news.

Last close · NASDAQ:FCSC

$3.00 USD

Close on Dec 12, 2019 · No longer trades

May 25, 2018 to last close +4.5% · weekly closes, May 25, 2018 – Dec 12, 2019
Lowest – highest close
$1.50 – $3.31 USDSince May 25, 2018 · lowest Dec 21, 2018 · highest Jun 21, 2018

Delisted NASDAQ:FCSC no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:FCSC
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Fibrocell Science Inc on 6ix

Decks
42 decks · latest Aug 15, 2019

Decks

DeckKindSlidesDate
Investor Presentation (August 2019)Investor deck22 slidesAug 15, 2019
Investor Presentation (July 2019)Investor deck22 slidesJul 2, 2019
Investor Presentation (May 2019)Investor deck22 slidesMay 29, 2019
Investor Presentation (March 2019)Investor deck22 slidesMar 27, 2019
Investor Presentation (January 2019)Investor deck24 slidesJan 8, 2019
Investor Presentation (November 2018)Investor deck24 slidesNov 13, 2018
Investor Presentation (October 2018)Investor deck24 slidesOct 4, 2018
Investor Presentation (September 2018)Investor deck24 slidesSep 5, 2018
Investor Presentation (August 2018)Investor deck24 slidesAug 9, 2018
Corporate Update (May 2018)Corporate update17 slidesMay 18, 2018
All 42 decks
DeckKindSlidesDate
Investor Presentation (May 2018)Investor deck21 slidesMay 10, 2018
Investor Presentation (March 2018)Investor deck21 slidesMar 19, 2018
Investor Presentation (March 2018)Investor deck21 slidesMar 6, 2018
Investor Presentation (February 2018)Investor deck21 slidesFeb 12, 2018
Investor Presentation (December 2017)Investor deck21 slidesDec 29, 2017
IPO Roadshow (November 2017)IPO roadshow21 slidesNov 17, 2017
Investor Presentation (November 2017)Investor deck21 slidesNov 15, 2017
Investor Presentation (October 2017)Investor deck20 slidesOct 4, 2017
Investor Presentation (August 2017)Investor deck18 slidesAug 9, 2017
Investor Presentation (June 2017)Investor deck18 slidesJun 21, 2017
Investor Presentation (May 2017)Investor deck19 slidesMay 22, 2017
20th Annual American Society of Gene & Cell Therapy Meeting (May 2017)Conference18 slidesMay 11, 2017
Technical Presentation (May 2017)Technical13 slidesMay 11, 2017
Investor Presentation (January 2017)Investor deck19 slidesJan 9, 2017
Investor Presentation (October 2016)Investor deck20 slidesOct 5, 2016
Investor Presentation (July 2016)Investor deck20 slidesJul 12, 2016
Investor Presentation (May 2016)Investor deck24 slidesMay 18, 2016
Investor Presentation (April 2016)Investor deck22 slidesApr 18, 2016
Investor Presentation (March 2016)Investor deck23 slidesMar 10, 2016
Investor Presentation (January 2016)Investor deck21 slidesJan 8, 2016
Investor Presentation (November 2015)Investor deck20 slidesNov 5, 2015
Investor Presentation (July 2015)Investor deck20 slidesJul 21, 2015
Investor Presentation (April 2015)Investor deck21 slidesApr 21, 2015
Biotech Showcase 2015Conference21 slidesJan 12, 2015
Investor Day (September 2014)Investor day112 slidesSep 24, 2014
Barclays Global Healthcare Conference 2014Conference28 slidesMar 12, 2014
Investor Presentation (January 2014)Investor deck31 slidesJan 13, 2014
Investor Presentation (May 2013)Investor deck36 slidesMay 7, 2013
OneMedForum (January 2013)Conference32 slidesJan 9, 2013
Investor Presentation (October 2012)Investor deck31 slidesOct 18, 2012
Investor Presentation (August 2012)Investor deck30 slidesAug 9, 2012
Technical Presentation (April 2011)Technical16 slidesApr 7, 2011

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Douglas J. Swirsky
Other companies: MaxCyte, Inc. (CHIEF FINANCIAL OFFICER · Since at least Mar 27, 2023); Cellectar Biosciences, Inc. (Director · Since at least Apr 10, 2017); MetaVia Inc. (Director · Sep 1, 2020 – Sep 1, 2020 · Past); Opus Genetics, Inc. (President and CEO, Director · Jan 2, 2018 – Jan 29, 2019 · Past); Pernix Therapeutics Holdings Inc (Director · Nov 15, 2017 – May 22, 2018 · Past); GenVec Inc (President and CEO, Director · Sep 18, 2006 – Jun 16, 2017 · Past)
Director · Mar 4, 2013 – Dec 13, 2019 · Past
Gregory L Weaver
Other companies: Altimmune, Inc. (Chief Financial Officer · Since at least Nov 11, 2024); Egalet Corporation (Director · Feb 5, 2014 – Jan 31, 2019 · Past); Atossa Therapeutics, Inc. (Former EVP, CFO, & Director, Director · Oct 10, 2013 – Nov 15, 2023 · Past); Imunon, Inc. (CFO · Mar 15, 2006 – Mar 19, 2013 · Past); Sirna Therapeutics Inc (Senior Vice President and CFO · Feb 13, 2006 – Dec 29, 2006 · Past)
Chief Financial Officer · Aug 26, 2013 – Jan 17, 2014 · Past
Keith A. Goldan
Other companies: Abeona Therapeutics Inc. (Director · Since at least Apr 1, 2026); Syndax Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Jun 13, 2022); OptiNose (Chief Financial Officer · Oct 12, 2017 – Mar 16, 2022 · Past); NuPathe Inc. (CFO and SVP · Aug 5, 2010 – Feb 21, 2014 · Past)
SVP and CFO · Mar 18, 2015 – Mar 1, 2016 · Past
Marc Mazur
Other companies: Soren Acquisition Corp. (Independent Director · Since at least Jan 6, 2026); SuRo Capital Corp. (Director · Since at least Jul 2, 2020); Celularity Inc. (Director · May 20, 2019 – Jun 14, 2023 · Past)
Director · Jun 22, 2016 – Dec 13, 2019 · Past
Michael F Marino III
Other companies: NewAmsterdam Pharma Company N.V. (See Remarks · Since at least May 27, 2025); OptiNose (Chief Legal Officer & Corp Sec · Oct 12, 2017 – May 21, 2025 · Past); NuPathe Inc. (SVP and General Counsel · Oct 7, 2010 – Feb 21, 2014 · Past)
SVP and General Counsel · Jun 1, 2015 – Mar 1, 2016 · Past
Christine St Clare
Other companies: Tilray Brands, Inc. (Director · Jul 18, 2018 – Apr 30, 2021 · Past); AquaBounty Technologies, Inc. (Director · Dec 30, 2016 – Jun 14, 2023 · Past)
Director · Feb 21, 2013 – Dec 13, 2019 · Past
Paul Hopper
Other companies: Scopus BioPharma, Inc. (Director · Dec 15, 2020 – Jun 1, 2021 · Past); EyePoint, Inc. (Director · Jul 9, 2008 – Dec 18, 2013 · Past)
Director · Sep 3, 2009 – Sep 25, 2009 · Past
David Pernock
Other companies: Eagle Pharmaceuticals, Inc. (Pres & Chief Operating Officer · Apr 8, 2015 – Feb 2, 2021 · Past)
Chairman and CEO, Director · Sep 3, 2009 – Dec 2, 2016 · Past
Henry Y L Toh
Other companies: Heritage Global Inc. (Director · Apr 3, 2006 – Mar 31, 2016 · Past)
Director · Dec 31, 2005 – Apr 4, 2008 · Past
John Michael Maslowski
Other companies: Research Alliance Corporation IV (Director · Since at least Jul 10, 2026)
CEO, Director · May 14, 2014 – Dec 13, 2019 · Past
All 28 people
PersonSeat
Julian P Kirk
Other companies: Armata Pharmaceuticals, Inc. (Director · Feb 18, 2014 – Sep 21, 2015 · Past)
Director · Oct 9, 2012 – Dec 13, 2019 · Past
Martin E Schmieg
Other companies: Lisata Therapeutics, Inc. (Vice President- Corporate Dev · Jun 25, 2012 – Jun 25, 2012 · Past)
CFO, Sr. VP · Dec 31, 2005 – Dec 31, 2005 · Past
Nicholas Teti
Other companies: ReShape Lifesciences Inc (Director · Nov 14, 2007 – Feb 8, 2017 · Past)
Director · Jun 5, 2006 – Dec 31, 2007 · Past
Todd James Greenspan
Other companies: C&D Technologies Inc (VP and Controller · Oct 1, 2009 – May 3, 2010 · Past)
Chief Financial Officer · Dec 31, 2005 – May 15, 2008 · Past
Declan DalyCOO & CFO, Director · Jun 5, 2006 – Apr 11, 2011 · Past
George J KorkosDirector · Jul 20, 2010 – May 24, 2012 · Past
Kelvin MooreDirector · Sep 3, 2009 – Dec 13, 2019 · Past
Kenneth A SelzerDirector · Nov 5, 2007 – May 14, 2008 · Past
Kimberly M SmithPrincipal Accounting Officer · Nov 7, 2016 – Nov 7, 2016 · Past
Marcus E SmithDirector · Oct 9, 2012 – Dec 13, 2019 · Past
Marshall G WebbDirector · Dec 31, 2005 – Apr 4, 2008 · Past
Ralph V DemartinoDirector · Dec 31, 2005 – Apr 4, 2008 · Past
Robert James SheroffVP, Technical Operations · Jan 6, 2014 – Jan 20, 2015 · Past
Sandra CalmanChief Medical Officer & V.P. · Feb 6, 2007 – Dec 31, 2007 · Past
Sean D BuckleyChief Financial Officer · Jun 19, 2018 – Dec 13, 2019 · Past
Steven MorrellDirector · Dec 31, 2005 – Apr 4, 2008 · Past
Susan Stranahan CiallellaPresident, Exec. VP & Sec., Director · Dec 31, 2005 – Dec 31, 2006 · Past
Terry E VandewarkerDirector · Oct 24, 2006 – Apr 4, 2008 · Past

Open People

Log in to ask 6ix AI your own questions about Fibrocell Science Inc.